RS20050971A - Emulsifying systems containing azetidine derivatives - Google Patents

Emulsifying systems containing azetidine derivatives

Info

Publication number
RS20050971A
RS20050971A YUP-2005/0971A YUP20050971A RS20050971A RS 20050971 A RS20050971 A RS 20050971A YU P20050971 A YUP20050971 A YU P20050971A RS 20050971 A RS20050971 A RS 20050971A
Authority
RS
Serbia
Prior art keywords
systems containing
azetidine derivatives
emulsifying systems
containing azetidine
derivatives
Prior art date
Application number
YUP-2005/0971A
Other languages
English (en)
Inventor
Sophie Cote
Valerie Bobineau
Maria-Teresa Peracchia
Original Assignee
Aventis Pharma S.A.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma S.A., filed Critical Aventis Pharma S.A.,
Publication of RS20050971A publication Critical patent/RS20050971A/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Emulgujući sistemi koji sadrže derivate azetidina. Ovaj pronalazak se odnosi na nove formulacije derivata azetidina za oralnu primenu.
YUP-2005/0971A 2003-07-18 2004-07-08 Emulsifying systems containing azetidine derivatives RS20050971A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03291797A EP1498123A1 (en) 2003-07-18 2003-07-18 Emulsifying systems containing azetidine derivatives
PCT/EP2004/008552 WO2005013972A1 (en) 2003-07-18 2004-07-08 Emulsifying systems containing azetidine derivatives

Publications (1)

Publication Number Publication Date
RS20050971A true RS20050971A (en) 2008-06-05

Family

ID=33462260

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-2005/0971A RS20050971A (en) 2003-07-18 2004-07-08 Emulsifying systems containing azetidine derivatives

Country Status (31)

Country Link
US (1) US20050037062A1 (sr)
EP (2) EP1498123A1 (sr)
JP (1) JP2009513559A (sr)
KR (1) KR20060040690A (sr)
CN (1) CN1822830A (sr)
AR (1) AR045912A1 (sr)
AU (1) AU2004262497A1 (sr)
BR (1) BRPI0412239A (sr)
CA (1) CA2532668A1 (sr)
CR (1) CR8178A (sr)
EC (1) ECSP066291A (sr)
GT (1) GT200400134A (sr)
HR (1) HRP20060021A2 (sr)
IL (1) IL173113A0 (sr)
MA (1) MA27921A1 (sr)
MX (1) MXPA06000478A (sr)
MY (1) MY142076A (sr)
NO (1) NO20060510L (sr)
NZ (1) NZ544707A (sr)
OA (1) OA13190A (sr)
PA (1) PA8606601A1 (sr)
PE (1) PE20050699A1 (sr)
RS (1) RS20050971A (sr)
RU (1) RU2348615C2 (sr)
SG (1) SG144140A1 (sr)
TN (1) TNSN06012A1 (sr)
TW (1) TW200522946A (sr)
UA (1) UA82539C2 (sr)
UY (1) UY28422A1 (sr)
WO (1) WO2005013972A1 (sr)
ZA (1) ZA200600489B (sr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1498122A1 (en) * 2003-07-18 2005-01-19 Aventis Pharma S.A. Semi-solid systems containing azetidine derivatives
EP1959926A1 (en) * 2005-10-25 2008-08-27 Abbott Laboratories Formulation comprising a drug of low water solubility and method of use thereof
CN102159143A (zh) * 2006-09-29 2011-08-17 普拉罗美德公司 碎石术期间预防结石和结石碎片后退的方法
PT2192893E (pt) * 2007-08-21 2015-11-09 Basilea Pharmaceutica Ag Composição antifúngica
FR2923719B1 (fr) * 2007-11-15 2009-11-20 Sanofi Aventis Compositions pharmaceutiques a base de derives d'azetidine
IT1394400B1 (it) * 2009-02-25 2012-06-15 Neuroscienze Pharmaness S C Ar L Composizioni farmaceutiche
WO2016164770A1 (en) 2015-04-10 2016-10-13 Bioresponse, L.L.C. Self-emulsifying formulations of dim-related indoles
CN106551902B (zh) * 2015-09-17 2020-07-03 阿赖耶识（上海）生物技术有限公司 一种高稳定的非囊泡型纳米颗粒及其在治疗微生物感染中的应用
JOP20190260A1 (ar) 2017-05-02 2019-10-31 Merck Sharp & Dohme صيغ ثابتة لأجسام مضادة لمستقبل الموت المبرمج 1 (pd-1) وطرق استخدامها
CA3060581A1 (en) 2017-05-02 2018-11-08 Merck Sharp & Dohme Corp. Formulations of anti-lag3 antibodies and co-formulations of anti-lag3 antibodies and anti-pd-1 antibodies
WO2022259205A1 (en) * 2021-06-11 2022-12-15 Universidade Da Beira Interior Self-emulsifying composition, production methods and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
JP2740153B2 (ja) * 1995-03-07 1998-04-15 エフ・ホフマン−ラ ロシユ アーゲー 混合ミセル
US6355631B1 (en) * 2000-03-03 2002-03-12 Aventis Pharma S.A. Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and their preparation
FR2814678B1 (fr) * 2000-10-04 2002-12-20 Aventis Pharma Sa Association d'un antagoniste du recepteur cb1 et de sibutramine, les compositions pharmaceutiques les contenant et leur utilisation pour la traitement de l'obesite
FR2829027A1 (fr) * 2001-08-29 2003-03-07 Aventis Pharma Sa Association avec un antagoniste du recepteur cb1, les compositions pharmaceutiques les contenant et leur utilisation pour le traitement de la maladie de parkinson
FR2833842B1 (fr) * 2001-12-21 2004-02-13 Aventis Pharma Sa Compositions pharmaceutiques a base de derives d'azetidine

Also Published As

Publication number Publication date
WO2005013972A1 (en) 2005-02-17
KR20060040690A (ko) 2006-05-10
BRPI0412239A (pt) 2006-09-12
EP1498123A1 (en) 2005-01-19
NO20060510L (no) 2006-01-31
JP2009513559A (ja) 2009-04-02
CN1822830A (zh) 2006-08-23
IL173113A0 (en) 2006-06-11
AU2004262497A2 (en) 2005-02-17
SG144140A1 (en) 2008-07-29
US20050037062A1 (en) 2005-02-17
AU2004262497A1 (en) 2005-02-17
PE20050699A1 (es) 2005-09-15
MY142076A (en) 2010-08-30
UA82539C2 (en) 2008-04-25
PA8606601A1 (es) 2005-03-03
RU2006105000A (ru) 2006-07-10
NZ544707A (en) 2009-01-31
HRP20060021A2 (en) 2006-02-28
CA2532668A1 (en) 2005-02-17
TNSN06012A1 (en) 2007-10-03
ZA200600489B (en) 2007-04-25
RU2348615C2 (ru) 2009-03-10
AR045912A1 (es) 2005-11-16
MA27921A1 (fr) 2006-06-01
UY28422A1 (es) 2005-02-28
GT200400134A (es) 2005-02-22
OA13190A (en) 2006-12-13
ECSP066291A (es) 2006-07-28
TW200522946A (en) 2005-07-16
MXPA06000478A (es) 2006-04-05
CR8178A (es) 2007-12-04
EP1648441A1 (en) 2006-04-26

Similar Documents

Publication Publication Date Title
HK1076605A1 (en) Formulations
TNSN06012A1 (en) Emulsifying systems containing azetidine derivatives
TW200621737A (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
NZ527867A (en) Oral pharmaceutical composition of cefpodoxime proxetil
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
AP1787A (en) Novel perindopril salt and pharmaceutical compositions containing same.
ZA200604874B (en) Pharmaceutical compositions
MXPA05008960A (es) Oxazolidinonas de indolona antibacteriales, intermedios para su preparacion y composiciones farmaceuticas que las contienen.
TNSN06013A1 (en) Semi-solid systems containing azetidine derivatives
MY139106A (en) Self-emulsifying and self-microemulsifying formulations for the oral administration of taxoids
MXPA06000636A (es) Formulaciones semi-solidas para la administracion oral de taxoides.
TW200503785A (en) Dosage form containing (S)-pantoprazole as active ingredient
MXPA03008801A (es) Aril oxima-piperazinas utiles como antagonistas de ccr5.
TW200503783A (en) Oral pharmaceutical preparation for proton pump antagonists
DE60212130D1 (en) Carvedilolpolymorph